Impact of Autologous Pure Platelet-rich Plasma in the Treatment of Tendon Disease
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Achilles Tendinitis
- Lateral Epicondylitis
- Rotator Cuff Tear
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 90 years
- Gender
- Both males and females
Description
All injection will be done under ultrasound guidance.
All injection will be done under ultrasound guidance.
Tracking Information
- NCT #
- NCT03300531
- Collaborators
- Zhejiang Xingyue Biotechnology Co., Ltd.
- Investigators
- Not Provided